Paracut Comp
Paracetamol 500 mg and caffeine 65 mg combination analgesic
Paracut Comp is a combination analgesic tablet containing paracetamol (acetaminophen) 500 mg and caffeine 65 mg per tablet. It is used for the short-term relief of mild-to-moderate pain such as tension headaches, migraine, muscle and joint pain, menstrual pain, dental pain, and the symptoms of colds and influenza. The addition of caffeine as an analgesic adjuvant enhances the pain-relieving effect of paracetamol by approximately 40%, according to Cochrane systematic reviews. This comprehensive guide covers indications, dosage, side effects, drug interactions, and essential safety information based on international clinical guidelines.
Quick Facts
Key Takeaways
- Paracut Comp contains paracetamol 500 mg and caffeine 65 mg per tablet and is indicated for mild-to-moderate pain and fever reduction.
- Caffeine acts as an analgesic adjuvant, enhancing paracetamol’s pain-relieving effect and improving absorption and onset of action.
- Never exceed 8 tablets (4 grams of paracetamol) in 24 hours — paracetamol overdose can cause severe, potentially fatal liver damage.
- Avoid alcohol during treatment and do not combine with other paracetamol-containing products, as this significantly increases the risk of hepatotoxicity.
- The caffeine content (equivalent to one small cup of coffee per tablet) may cause insomnia or palpitations; avoid taking close to bedtime.
What Is Paracut Comp and What Is It Used For?
Paracut Comp is a fixed-dose combination tablet that brings together two well-established active substances: paracetamol (known as acetaminophen in the United States) at a dose of 500 mg, and caffeine at a dose of 65 mg. This combination has been used clinically for decades and is supported by extensive evidence demonstrating superior analgesic efficacy compared to paracetamol alone for certain types of pain. The addition of caffeine functions as an analgesic adjuvant, meaning that although caffeine itself has only limited direct pain-relieving properties, it significantly enhances the effect of the primary analgesic.
The mechanism of paracetamol remains incompletely understood despite its widespread use. The prevailing scientific consensus is that paracetamol exerts its analgesic and antipyretic effects primarily through central inhibition of cyclooxygenase (COX) enzymes, particularly a COX-2 variant in the central nervous system. Unlike non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol has negligible peripheral anti-inflammatory activity and does not significantly inhibit platelet function. Additional mechanisms include activation of descending serotonergic pain-modulating pathways, interaction with the endocannabinoid system via its metabolite AM404, and modulation of TRPV1 receptors.
Caffeine, a methylxanthine derivative, contributes to the analgesic effect through several pathways. It is a non-selective antagonist of adenosine receptors (A1 and A2A), which plays a role in central pain modulation. Caffeine also enhances the gastrointestinal absorption of paracetamol, leading to higher peak plasma concentrations and faster onset of action. Furthermore, caffeine’s mild central nervous system stimulant effect may counteract the fatigue and malaise that often accompany painful conditions such as headaches and influenza, thereby improving the patient’s overall sense of well-being during treatment.
Paracut Comp 500 mg/65 mg is indicated for the short-term symptomatic treatment of the following conditions, in line with recommendations from the World Health Organization (WHO), the British National Formulary (BNF), and the International Association for the Study of Pain (IASP):
- Tension-type headache — the most common primary headache disorder, where paracetamol-caffeine combinations show consistent benefit
- Migraine attacks — for mild-to-moderate episodes not requiring triptan therapy, particularly when accompanied by tension-type features
- Musculoskeletal pain — including low back pain, minor sports injuries, and muscular strain
- Dysmenorrhoea (menstrual pain) — as an alternative when NSAIDs are contraindicated or poorly tolerated
- Dental pain — including post-extraction pain and toothache awaiting dental treatment
- Cold and influenza symptoms — for the relief of associated fever, headache, and body aches
- Postoperative pain — as part of a multimodal analgesia strategy for mild-to-moderate postoperative discomfort
- Fever reduction (antipyresis) — in adults and adolescents, particularly when accompanied by headache
It is important to emphasise that Paracut Comp is intended for short-term, symptomatic relief. Regular or prolonged use (more than 10 days for adults) should only occur under medical supervision, as persistent or worsening pain may indicate an underlying condition requiring specific treatment. Additionally, frequent use of combination analgesics containing caffeine has been associated with an increased risk of medication-overuse headache, a condition where the analgesic itself perpetuates the headache cycle when taken too often.
A Cochrane systematic review (Derry et al., 2014) analysing randomised controlled trials in postoperative pain demonstrated that adding caffeine 65–130 mg to paracetamol provides a small but statistically significant additional analgesic benefit, with a number needed to treat (NNT) of approximately 17 for an additional 50% pain relief. Although modest, this benefit is clinically meaningful for many patients.
What Should You Know Before Taking Paracut Comp?
Before beginning treatment with Paracut Comp, your doctor or pharmacist should review your complete medical history, current medications, and lifestyle factors to ensure the medicine is appropriate for you. Although both paracetamol and caffeine are among the most widely consumed pharmacological substances in the world, combined with the specific 500 mg/65 mg dosage form, several important safety considerations apply. Understanding these factors is essential to minimise the risk of adverse events and maximise therapeutic benefit.
Contraindications
You must not take Paracut Comp if any of the following apply to you:
- Known hypersensitivity to paracetamol, caffeine, or any of the excipients in the tablet — including previous allergic reactions such as rash, urticaria, angioedema, or anaphylaxis
- Severe hepatic (liver) impairment — including acute hepatitis, decompensated cirrhosis, or significant transaminase elevations, as paracetamol is metabolised primarily in the liver
- Severe renal (kidney) impairment — defined as a glomerular filtration rate (GFR) below 30 mL/min/1.73m²
- Chronic alcoholism or heavy alcohol consumption — significantly increases the risk of paracetamol-induced liver toxicity even at therapeutic doses
- Severe cardiovascular disease — including unstable angina, recent myocardial infarction, or uncontrolled arrhythmias where caffeine’s cardiovascular effects could be harmful
- Concurrent use of monoamine oxidase inhibitors (MAOIs) — including phenelzine, tranylcypromine, and selegiline, due to the risk of hypertensive crisis with caffeine
- Uncontrolled severe hypertension — where caffeine’s pressor effects could be problematic
- Children under 12 years of age — this strength and combination is not appropriate for younger children, who require paediatric paracetamol formulations without caffeine
Warnings and Precautions
Exercise caution and consult your doctor before using Paracut Comp if you have any of the following conditions:
- Mild-to-moderate hepatic impairment — dose adjustment may be required; maximum daily dose typically reduced to 2–3 grams of paracetamol
- Gilbert’s syndrome — a hereditary condition causing reduced glucuronidation, which may slightly increase paracetamol levels
- Chronic malnutrition or low body weight — depleted glutathione stores increase susceptibility to paracetamol toxicity
- Dehydration or hypovolaemia — may increase the risk of acute kidney injury
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency — rarely, paracetamol has been associated with haemolysis in affected individuals
- Anxiety disorders or panic disorder — caffeine may precipitate or worsen symptoms
- Peptic ulcer disease — although paracetamol is generally gentler than NSAIDs, caffeine may increase gastric acid secretion
- Thyroid disease — particularly hyperthyroidism, where caffeine may exacerbate symptoms such as tachycardia and tremor
- Asthma — rare cases of paracetamol-induced bronchospasm have been reported in sensitive individuals
- History of serious skin reactions — including Stevens-Johnson syndrome, toxic epidermal necrolysis, or acute generalised exanthematous pustulosis
Paracetamol at doses above the recommended maximum can cause severe, potentially fatal liver damage. The risk is increased by: exceeding 4 grams per 24 hours; combining with other paracetamol-containing products (including cold remedies, analgesics, and sleep aids); consuming alcohol regularly; malnutrition; and use of enzyme-inducing drugs such as rifampicin, phenobarbital, phenytoin, carbamazepine, or St John’s wort. Always check the ingredients of all medicines you take, and never exceed 8 tablets of Paracut Comp in any 24-hour period.
Pregnancy and Breastfeeding
The use of Paracut Comp during pregnancy requires careful consideration of the benefits and risks of each component. Paracetamol has long been considered the analgesic of choice during pregnancy, as extensive epidemiological data has established a favourable safety profile at therapeutic doses. However, recent research has prompted more cautious recommendations. A 2021 consensus statement published in Nature Reviews Endocrinology by 91 scientists and clinicians suggested that pregnant women should be counselled to use paracetamol only when medically indicated, at the lowest effective dose, and for the shortest possible duration, pending further research into potential associations with neurodevelopmental and urogenital outcomes.
The caffeine component introduces additional considerations. High caffeine intake during pregnancy (over 200–300 mg per day from all sources) has been associated with increased risk of miscarriage, low birth weight, and preterm birth. A single Paracut Comp tablet contains 65 mg of caffeine, and at the maximum daily dose of 8 tablets, caffeine intake would reach 520 mg from this source alone — well above the World Health Organization’s recommended limit for pregnancy. Therefore, if regular analgesia is required during pregnancy, plain paracetamol without caffeine is generally preferred.
Regarding breastfeeding, both paracetamol and caffeine pass into breast milk, but in small amounts considered generally compatible with breastfeeding at therapeutic doses. The relative infant dose for paracetamol is approximately 6%, well below the 10% threshold used to assess breastfeeding safety. Caffeine accumulates more in breastfed infants, particularly in neonates whose liver enzymes are immature. Occasional use of Paracut Comp is usually acceptable, but regular use may cause irritability, poor sleep, and tremors in the infant. The lactating mother should consider timing doses immediately after breastfeeding to minimise infant exposure, and monitor the baby for signs of restlessness or feeding difficulties.
Effects on Driving and Operating Machinery
Paracetamol at therapeutic doses does not typically impair driving ability or the operation of machinery. Caffeine’s stimulant effects may actually improve alertness in some individuals. However, in sensitive persons, caffeine can cause side effects such as tremor, restlessness, or rapid heartbeat that could theoretically affect performance. If you experience any such symptoms, avoid driving or operating hazardous machinery until they resolve.
How Does Paracut Comp Interact with Other Drugs?
Both paracetamol and caffeine interact with a number of commonly prescribed medications. Understanding these interactions is essential to ensure treatment safety and efficacy. The following tables summarise the most clinically significant drug interactions based on international pharmacology references including the British National Formulary, Stockley’s Drug Interactions, and the EMA’s Summary of Product Characteristics for combination paracetamol products.
Major Interactions
| Drug/Class | Interaction Effect | Clinical Recommendation |
|---|---|---|
| Other paracetamol-containing products | Cumulative paracetamol exposure may exceed safe thresholds, causing severe hepatotoxicity. Paracetamol is present in many cold, flu, and combination pain products | Never combine. Always check ingredients of all analgesics, cold remedies, and prescription pain medicines before taking Paracut Comp |
| Warfarin and coumarin anticoagulants | Regular use of paracetamol (more than 2 g/day for >1 week) may increase INR and bleeding risk by inhibiting vitamin K-dependent clotting factor synthesis | Occasional use is generally safe; regular daily use requires more frequent INR monitoring, especially during first 2 weeks |
| MAO inhibitors (phenelzine, selegiline) | Caffeine combined with MAOIs can precipitate hypertensive crisis due to impaired caffeine metabolism and catecholamine release | Contraindicated during MAOI therapy and for 2 weeks after discontinuation of MAOI |
| Enzyme inducers (rifampicin, phenytoin, carbamazepine, phenobarbital, St John’s wort) | Induction of CYP2E1 and other enzymes increases conversion of paracetamol to the toxic metabolite NAPQI, raising liver toxicity risk | Use lowest effective paracetamol dose; consider alternatives for prolonged treatment; monitor for hepatotoxicity |
| Quinolone antibiotics (ciprofloxacin, norfloxacin, enoxacin) | Inhibit caffeine metabolism via CYP1A2, increasing caffeine plasma levels by up to 100% and prolonging half-life | Monitor for caffeine toxicity symptoms (tachycardia, tremor, insomnia); reduce caffeine intake during therapy |
| Alcohol (ethanol) | Chronic alcohol consumption induces CYP2E1, increasing NAPQI formation and hepatotoxicity risk at any paracetamol dose | Avoid or strictly limit alcohol consumption during treatment; those with chronic alcohol use should use paracetamol with extreme caution |
Minor to Moderate Interactions
| Drug/Class | Interaction Effect | Clinical Recommendation |
|---|---|---|
| Metoclopramide and domperidone | Increase gastric emptying rate, accelerating paracetamol absorption and earlier peak plasma levels | Clinically beneficial in migraine; no dose adjustment required |
| Cholestyramine | Reduces paracetamol absorption by approximately 30% when taken within 1 hour | Take Paracut Comp at least 1 hour before or 4–6 hours after cholestyramine |
| Theophylline | Caffeine has similar pharmacology to theophylline; additive central nervous system stimulation and increased toxicity risk | Monitor theophylline levels; reduce caffeine intake; avoid combination during theophylline loading |
| Oral contraceptives | Reduce caffeine clearance by up to 40% through CYP1A2 inhibition; prolong caffeine half-life | Women on oral contraceptives may be more sensitive to caffeine’s effects; use lowest effective Paracut Comp dose |
| Lithium | Caffeine increases renal clearance of lithium; sudden withdrawal of regular caffeine intake may cause lithium toxicity | Maintain consistent caffeine intake; monitor lithium levels if starting or stopping regular Paracut Comp use |
| Adenosine (used in cardiac testing) | Caffeine is a direct antagonist at adenosine receptors, potentially reducing efficacy of pharmacological stress testing | Avoid caffeine (including Paracut Comp) for at least 24 hours before adenosine-based cardiac stress tests |
| Fluvoxamine (SSRI) | Potent CYP1A2 inhibition dramatically increases caffeine exposure — half-life may increase 5-fold | Reduce caffeine intake significantly; monitor for insomnia, anxiety, and palpitations |
| Probenecid | Reduces paracetamol clearance by almost 50% through inhibition of glucuronidation | Dose reduction of Paracut Comp may be required; avoid maximum daily doses |
Beyond these specific drug interactions, patients should be aware that many over-the-counter products contain paracetamol. Multi-symptom cold and flu remedies, night-time sleep aids, migraine preparations, and various prescription pain medications frequently include paracetamol as a component. Accidental overdose through unwitting combination is a leading cause of paracetamol-induced liver failure in both Europe and North America. Always read product labels carefully and consult your pharmacist before combining Paracut Comp with any other medication, supplement, or herbal product.
Remember that caffeine is present in coffee, tea, chocolate, cola drinks, energy drinks, and some pre-workout supplements. One average cup of coffee contains 80–100 mg of caffeine, so taking 2 Paracut Comp tablets (130 mg of caffeine) combined with even moderate dietary caffeine intake can quickly exceed recommended limits of 400 mg/day for healthy adults.
What Is the Correct Dosage of Paracut Comp?
The dosage of Paracut Comp should be individualised based on age, body weight, the nature and severity of pain, and any hepatic or renal impairment. The guidance below reflects standard recommendations from international prescribing resources, but patients must always follow the specific instructions of their prescriber or pharmacist. The fundamental principle of paracetamol dosing is that it should be given at the lowest effective dose for the shortest duration necessary.
Adults
Standard Adult Dose
1 to 2 tablets every 4 to 6 hours as required for pain or fever. The maximum single dose is 2 tablets (paracetamol 1 g + caffeine 130 mg), and the maximum daily dose is 8 tablets in any 24-hour period (paracetamol 4 g + caffeine 520 mg). Leave a minimum of 4 hours between doses. Do not take the medicine for more than 3 consecutive days for fever or 10 consecutive days for pain without medical advice.
Adults with Low Body Weight (under 50 kg)
In adults weighing less than 50 kg, the total daily paracetamol dose should not exceed 60 mg/kg/day (equivalent to approximately 6 tablets maximum for a 50 kg adult). The use of paracetamol at maximum doses should be avoided in underweight individuals due to reduced capacity for metabolism.
Adults with Hepatic Impairment or Chronic Alcohol Use
In patients with mild-to-moderate liver dysfunction or a history of chronic alcohol consumption, the maximum daily dose should be reduced to 2–3 grams of paracetamol (4–6 tablets of Paracut Comp). In severe liver disease, the medicine is contraindicated. Paracetamol alternatives or other analgesics should be considered.
Children
Paracut Comp 500 mg/65 mg is not suitable for children under 12 years of age. This restriction is based on two considerations: the tablet strength (500 mg paracetamol) exceeds appropriate paediatric doses, and the caffeine content is inappropriate for younger children. For children aged 2 to 11 years who need paracetamol, weight-based paediatric formulations (suspensions, soluble tablets, or suppositories) should be used at a dose of 15 mg/kg every 4–6 hours, maximum 60 mg/kg/day. Children aged 12 to 17 years may use Paracut Comp at the standard adult dose, though many clinicians prefer plain paracetamol for this age group unless additional analgesic efficacy is specifically required.
Elderly
Elderly patients (65 years and older) generally do not require dose adjustment for paracetamol at standard doses, as hepatic clearance of paracetamol is relatively preserved with ageing. However, several considerations apply. Older adults may be more sensitive to caffeine’s cardiovascular and central nervous system effects, including palpitations, tremor, insomnia, and increased anxiety. Frailty, polypharmacy, and age-related decline in renal function all increase the risk of adverse drug reactions. The NICE guidelines recommend starting at the lower end of the dose range (1 tablet every 6 hours) and titrating based on response and tolerance. Evening doses should be avoided in elderly patients prone to insomnia.
Patients with Renal Impairment
In patients with severe renal impairment (GFR < 30 mL/min), the interval between doses should be extended to at least 6 hours, and the daily dose should be reduced. Paracetamol and its metabolites are excreted renally, and accumulation may occur in advanced kidney disease. In end-stage renal disease or haemodialysis, specialist consultation is recommended before prescribing.
Method of Administration
Paracut Comp tablets should be swallowed whole with a glass of water. They may be taken with or without food, although taking them with food may reduce the risk of gastrointestinal irritation in sensitive individuals. The tablets should not be crushed or chewed unless specifically indicated for a particular brand. Due to caffeine’s stimulant effect, avoid taking Paracut Comp within 4–6 hours of bedtime to prevent sleep disturbance.
Missed Dose
Paracut Comp is taken on an “as needed” basis rather than on a fixed schedule, so the concept of a missed dose does not strictly apply. If you are taking it at regular intervals for persistent pain and miss a dose, take the next dose when needed, but ensure at least 4 hours have passed since the previous dose. Do not double-dose to make up for a missed dose, as this increases the risk of exceeding the maximum daily paracetamol limit.
Overdose
Paracetamol overdose is a medical emergency and requires immediate attention, even if the person appears well. This is because the early clinical presentation of paracetamol poisoning is often mild or absent — with only nausea, vomiting, pallor, and malaise in the first 24 hours — while severe, potentially fatal liver damage develops silently over 24–72 hours. Ingestion of more than 150 mg/kg or 12 grams (whichever is lower) is considered potentially toxic, but lower doses may be toxic in patients with risk factors such as chronic alcohol use, malnutrition, or concurrent enzyme-inducing drugs.
Caffeine overdose contributes additional symptoms when very high doses of Paracut Comp are ingested. These include severe agitation, tremor, tachycardia, arrhythmias, hypertension, seizures, and in extreme cases, cardiac arrest. Caffeine doses above 5 grams are considered potentially lethal in adults.
If you or someone else has taken too many Paracut Comp tablets, seek immediate medical attention, even if no symptoms are present. Take the medicine packaging to the hospital if possible. The antidote for paracetamol poisoning, N-acetylcysteine (NAC), is highly effective when given within 8 hours of ingestion, but becomes progressively less effective with delay. Do not attempt to induce vomiting unless specifically instructed by a medical professional or poisons information service. Contact your local emergency number or poisons information centre immediately.
What Are the Side Effects of Paracut Comp?
Paracut Comp is generally well tolerated when used at recommended doses for short-term relief. Side effects most commonly relate to the caffeine component at usual therapeutic doses, while paracetamol-related adverse effects tend to be uncommon but can be severe when they occur, particularly with overdose. The following classification follows MedDRA conventions used by the European Medicines Agency and other international regulatory bodies.
Very Common
Affects more than 1 in 10 people
- Mild gastrointestinal upset (with higher doses or empty stomach)
- Transient alertness or increased energy (from caffeine)
Common
Affects 1 in 10 to 1 in 100 people
- Nervousness, restlessness, or jitteriness
- Insomnia or difficulty falling asleep
- Palpitations or increased heart rate
- Mild tremor, particularly of the hands
- Headache (particularly with rebound or withdrawal)
- Nausea and mild abdominal discomfort
- Increased urinary frequency (diuretic effect of caffeine)
Uncommon
Affects 1 in 100 to 1 in 1,000 people
- Anxiety or panic attacks in susceptible individuals
- Dizziness and lightheadedness
- Skin rash or pruritus (itching)
- Transient elevation of liver enzymes (ALT/AST)
- Cardiac arrhythmias (particularly at higher caffeine doses)
- Hypertension (mild and transient)
- Tinnitus (ringing in the ears)
- Medication-overuse headache (with frequent long-term use)
Rare and Very Rare
Affects fewer than 1 in 1,000 people
- Anaphylaxis and severe allergic reactions
- Angioedema (swelling of face, lips, tongue, or throat)
- Stevens-Johnson syndrome and toxic epidermal necrolysis (life-threatening skin reactions)
- Acute generalised exanthematous pustulosis (AGEP)
- Hepatotoxicity and acute liver failure (primarily with overdose or in predisposed patients)
- Acute kidney injury and interstitial nephritis
- Thrombocytopenia, leukopenia, or agranulocytosis
- Haemolytic anaemia (in G6PD deficiency)
- Bronchospasm in aspirin/NSAID-sensitive asthmatics
- Seizures (with very high caffeine doses)
If you experience any of the following symptoms, stop taking the medication and seek medical attention immediately: any sign of allergic reaction including swelling of the face, lips, tongue, or throat, difficulty breathing, or widespread hives; skin blistering, peeling, or mucosal ulceration; yellowing of the skin or eyes (jaundice); dark urine; severe upper right abdominal pain; unusual bleeding or bruising; or marked decrease in urine output. Severe skin reactions such as Stevens-Johnson syndrome are extremely rare but may be fatal; early recognition and treatment are critical.
The cardiovascular effects of caffeine, while usually mild, may be pronounced in caffeine-sensitive individuals or those already consuming significant amounts of caffeine from dietary sources. Symptoms such as palpitations, chest discomfort, or marked tachycardia should prompt cessation of the medicine and medical evaluation, particularly in patients with known cardiovascular disease.
Chronic use of paracetamol-caffeine combinations beyond short-term indications can lead to medication-overuse headache, a condition recognised by the International Headache Society in which frequent analgesic use paradoxically perpetuates or worsens headaches. This is particularly relevant for patients with tension-type headache or migraine, and is more likely when analgesics are taken on more than 10 days per month for 3 or more consecutive months.
You can help improve drug safety by reporting any suspected side effects to your national medicines regulatory authority. In Europe, report to the European Medicines Agency (EMA) or your national authority. In the United States, the FDA MedWatch programme accepts reports. In the United Kingdom, the MHRA Yellow Card scheme is used. In Australia, the TGA Adverse Event Reporting system is available. Reporting helps identify rare side effects and improve treatment safety for everyone.
How Should You Store Paracut Comp?
Proper storage of Paracut Comp is essential to maintain the stability, potency, and safety of the active ingredients throughout the product’s shelf life. Both paracetamol and caffeine are relatively stable compounds at room temperature, but exposure to heat, humidity, and light can accelerate degradation and potentially produce less effective or even harmful breakdown products. Follow these storage recommendations carefully.
- Temperature: Store at room temperature, not above 25°C (77°F). Avoid storage in locations subject to temperature extremes such as near radiators, stoves, in direct sunlight, in parked vehicles, or in bathrooms where humidity and heat fluctuate significantly.
- Moisture protection: Keep the tablets in the original blister packaging until immediately before taking. Moisture can cause chemical degradation of paracetamol and compromise tablet integrity. Avoid storing in bathroom medicine cabinets, which experience humidity changes during showering.
- Light protection: Keep the medicine in its original outer carton to protect from direct light exposure, which can accelerate degradation of some components.
- Child safety: Store Paracut Comp well out of sight and reach of children. Paracetamol overdose is a leading cause of accidental poisoning in children, and the sweet or tablet form may appear attractive. Consider using a locked medicine cabinet if children are present in the home.
- Expiry date: Check the expiry date printed on the blister foil and outer carton before each use. The expiry date refers to the last day of the stated month. Do not use the medicine after this date, as efficacy and safety cannot be guaranteed.
- Visual inspection: Before taking a tablet, check that it has its normal appearance. Do not use tablets that appear discoloured, crumbled, or unusual in any way. If the blister packaging is damaged, consult your pharmacist.
Do not dispose of unused or expired Paracut Comp tablets by flushing them down the toilet or sink, or by placing them in household waste. Pharmaceutical residues can contaminate water systems and harm the environment. Instead, return any unused or expired medicines to your local pharmacy, which operates authorised medicine take-back programmes in most countries. This system ensures safe disposal in accordance with environmental regulations and prevents accidental ingestion by others.
If you need to travel with Paracut Comp, keep it in its original packaging and transport it in your carry-on luggage to avoid temperature extremes in airline cargo holds. Customs regulations vary by destination, so check whether combination analgesics containing caffeine are permitted at your destination, particularly if travelling with larger quantities.
What Does Paracut Comp Contain?
Understanding the complete composition of your medicine is important for safety, particularly if you have known allergies, intolerances, or dietary restrictions. Each Paracut Comp tablet is formulated to deliver a precise dose of two active pharmaceutical ingredients, together with several pharmaceutically inactive excipients that serve specific functional roles in tablet manufacturing and performance.
Active Ingredients
- Paracetamol (acetaminophen) — 500 mg per tablet. This is the principal analgesic and antipyretic component. Paracetamol is one of the most widely used medicines in the world, included on the WHO Model List of Essential Medicines. It acts primarily on the central nervous system to reduce pain perception and lower body temperature during fever. Paracetamol has minimal anti-inflammatory activity at therapeutic doses.
- Caffeine — 65 mg per tablet. Caffeine is included as an analgesic adjuvant. At this dose, it acts pharmacologically rather than simply as a stimulant, enhancing the pain-relieving effect of paracetamol through adenosine receptor antagonism and improved paracetamol absorption. For reference, 65 mg of caffeine is equivalent to approximately one small cup of instant coffee or a can of cola drink.
Excipients (Inactive Ingredients)
The excipients used in Paracut Comp tablets serve various manufacturing and pharmaceutical purposes including tablet binding, disintegration, flow properties, and coating. While specific excipients may vary between manufacturers and batches, combination paracetamol-caffeine tablets typically contain:
- Pregelatinised starch or maize starch — functions as both a binder and disintegrant, helping the tablet hold together during manufacturing and then break apart upon contact with gastrointestinal fluid
- Microcrystalline cellulose — a widely used filler and binder that provides structural integrity and assists with tablet compression
- Povidone (polyvinylpyrrolidone) — a binder that helps the tablet ingredients adhere during granulation
- Sodium starch glycolate or croscarmellose sodium — a superdisintegrant that rapidly breaks the tablet apart in the stomach for quick release of active ingredients
- Colloidal anhydrous silica — a glidant that improves powder flow during tablet manufacturing and ensures dose uniformity
- Magnesium stearate or stearic acid — a lubricant that prevents the tablet mixture from sticking to manufacturing equipment
- Talc — sometimes used as an additional glidant or in tablet coatings
- Film-coating agents (such as hypromellose, titanium dioxide, or polyethylene glycol) — applied to some formulations to improve appearance, mask taste, and ease swallowing
If you have known lactose intolerance, gluten sensitivity (celiac disease), or other dietary sensitivities, consult the patient information leaflet supplied with your specific batch, as excipient composition may vary between manufacturers. If any of the excipients listed on the product label cause concern, speak with your pharmacist before taking the medicine. Some patients with severe starch-related allergies may need to consider alternative formulations.
Paracut Comp does not contain common pharmaceutical allergens such as aspirin (acetylsalicylic acid), codeine, tramadol, ibuprofen, or other NSAIDs. It also does not contain opioid substances, and it does not cause dependence or tolerance in the same way as opioid analgesics. However, as with any analgesic, long-term frequent use should be avoided outside of specific medical indications.
Appearance and Pack Size
Paracut Comp is typically supplied as white to off-white, round or oblong film-coated tablets, although exact appearance (shape, score line, imprinting) depends on the specific manufacturer. Tablets are packaged in aluminium blister strips to protect them from moisture and light. Pack sizes vary by country and pharmacy, commonly ranging from 10 to 100 tablets per carton. Always check the outer carton for batch number and expiry date.
Frequently Asked Questions
References
This article is based on the following peer-reviewed sources and international clinical guidelines:
- Derry CJ, Derry S, Moore RA. “Caffeine as an analgesic adjuvant for acute pain in adults.” Cochrane Database of Systematic Reviews, 2014;12:CD009281. doi:10.1002/14651858.CD009281.pub3
- Graham GG, Davies MJ, Day RO, et al. “The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.” Inflammopharmacology, 2013;21(3):201–232. doi:10.1007/s10787-013-0172-x
- World Health Organization (WHO). “WHO Model List of Essential Medicines — 23rd List.” 2023.
- British National Formulary (BNF). “Paracetamol with caffeine.” Accessed January 2026.
- National Institute for Health and Care Excellence (NICE). “Analgesia - mild-to-moderate pain.” Clinical Knowledge Summaries, Updated 2024.
- Bauer AZ, Swan SH, Kriebel D, et al. “Paracetamol use during pregnancy — a call for precautionary action.” Nature Reviews Endocrinology, 2021;17(12):757–766. doi:10.1038/s41574-021-00553-7
- European Medicines Agency (EMA). “Summary of Product Characteristics: Paracetamol/Caffeine combination products.” Accessed January 2026.
- Chen LH, Fang J, Sun Z, et al. “Chronic caffeine exposure during pregnancy: risks and outcomes.” Nutrients, 2020;12(9):2792. doi:10.3390/nu12092792
- Laska EM, Sunshine A, Mueller F, et al. “Caffeine as an analgesic adjuvant.” JAMA, 1984;251(13):1711–1718. doi:10.1001/jama.1984.03340370043028
- International Headache Society. “The International Classification of Headache Disorders, 3rd edition (ICHD-3).” Cephalalgia, 2018;38(1):1–211.
- Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. “The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache.” Cephalalgia, 2005;25(10):776–787.
- Larson AM, Polson J, Fontana RJ, et al. “Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.” Hepatology, 2005;42(6):1364–1372. doi:10.1002/hep.20948
- Food and Drug Administration (FDA). “Acetaminophen Information.” Updated 2024.
- Nehlig A. “Interindividual differences in caffeine metabolism and factors driving caffeine consumption.” Pharmacological Reviews, 2018;70(2):384–411. doi:10.1124/pr.117.014407
- Stockley IH. Stockley’s Drug Interactions. 12th edition. London: Pharmaceutical Press; 2022.
Medical Editorial Team
This article has been written and reviewed by qualified medical professionals to ensure clinical accuracy and adherence to international guidelines.
Medical Content
Written by the iMedic Medical Editorial Team — specialists in clinical pharmacology, pain medicine, and internal medicine with documented academic background and clinical experience.
Medical Review
Reviewed by the iMedic Medical Review Board — an independent panel of physicians ensuring all content meets evidence-based standards (WHO, EMA, FDA, NICE, BNF).
Evidence Standards
All medical claims follow the GRADE evidence framework. This article is based on Level 1A evidence from systematic reviews and meta-analyses of randomised controlled trials.
Editorial Independence
iMedic receives no commercial funding from pharmaceutical companies. All content is editorially independent and free from commercial influence.